Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-20-078960
Filing Date
2020-03-19
Accepted
2020-03-19 16:07:06
Documents
1
Period of Report
2020-05-12

Document Format Files

Seq Description Document Type Size
1 PRE 14A d896809dpre14a.htm PRE 14A 421653
  Complete submission text file 0001193125-20-078960.txt   422896
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 033-80623 | Film No.: 20728517
SIC: 2835 In Vitro & In Vivo Diagnostic Substances